Hepion Pharmaceuticals Inc (NASDAQ:HEPA)

3.43
Delayed Data
As of Sep 18
 -0.17 / -4.72%
Today’s Change
1.00
Today|||52-Week Range
8.35
-36.01%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization16.4K21.5K21.9K18.8K
 
 
 
 
 
 
Operating ExpensesGross Income-16.4K-21.5K-21.9K-18.8K
 
 
 
 
 
General Expenses13.9M20.6M21.0M14.6M
 
 
 
 
 
Research And Development8.4M15.0M14.3M7.6M
 
 
 
 
 
Total Operating Expenses14.0M20.6M21.0M14.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-14.0M-20.6M-21.0M-14.6M
 
 
 
 
 
Extraordinary Credit0.003.8M1.1M5.3M
 
 
 
 
Extraordinary Charge-387.9K-214.0K0.00-374.3K
 
 
 
 
Interest Expense On Debt0.00--0.00339.2K
 
 
Other Expenses0.000.001.1M0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.3M-17.0M-18.9M-10.0M
 
 
 
 
 
Income Taxes0.000.00-3.9M-536.0K
 
 
 
Preferred Dividend-7.8M0.000.00-8.5M
 
 
 
Net Income-14.3M-17.0M-15.0M-9.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS38.8K48.3K138.3K183.9K
 
 
 
 
 
Shares To Calculate EPS Diluted38.8K48.3K138.3K183.9K
 
 
 
 
 
 
Earnings Per ShareEPS-$571.20-$352.80-$56.00-$97.30
 
 
 
 
 
EPS Diluted-$571.20-$352.80-$106.40-$97.35